Background Cannabidiol (CBD) is the second most abundant pharmacologically active
component present in Cannabis sp. Unlike Δ-9-tetrahydrocannabinol (THC), it has no …

Recent studies have shown that cannabidiol (CBD) could have a great therapeutic potential
for treating disorders such as chronic pain and anxiety. In the target article, the authors …

Cannabidiol (CBD) is the most abundant non-psychoactive component found in plants of the
genus Cannabis. Its analgesic effect for the treatment of neuropathy has been widely …

Chronic neuropathic pain (CNP) is a vast world health problem often associated with the
somatosensory domain. This conceptualization is problematic because, unlike most other …

Background Cannabis, more commonly known as marijuana or hemp, has been used for
centuries to treat various conditions. Cannabis contains two main components cannabidiol …

The incidence of chronic pain is high in the general population and it is closely related to
anxiety disorders, which promote negative effects on the quality of life. The cannabinoid …

Objectives Pain is the most common cause of seeking healthcare and the leading cause of
disability worldwide. Although cannabidiol and transcutaneous electrical nerve stimulation …

Neuropathic pain (NP) is a complex health problem that includes sensorial manifestations
such as evoked and ongoing pain. Cannabidiol (CBD) has shown potential in the treatment …

Neuropathic pain (NP) arises as a direct consequence of traumatic spinal cord injury (SCI),
which leads to devastating consequences for people suffering from this condition since no …

Most diabetic patients describe moderate to severe pain symptoms whose pharmacological
treatment is palliative and poorly effective. Cannabidiol (CBD) has shown promising results …